Tag: Numinus - Psychedelic Alpha

Numinus Wellness Inc. Reports Q4 2022 and Annual Results

Post published:December 2, 2022
Post category:Press Release

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022

Post published:November 23, 2022
Post category:Press Release

Numinus Re-Launches “Psychedelic Therapy Frontiers” Podcast with additional hosts and topics

Post published:November 1, 2022
Post category:Press Release

Numinus to Participate in Wonderland: Miami on November 3-5, 2022

Post published:October 31, 2022
Post category:Press Release

Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness

Post published:October 28, 2022
Post category:Press Release

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022

Post published:October 8, 2022
Post category:Press Release

Numinus Develops Mushroom Tea for Use in Psychedelic Research

Post published:October 6, 2022
Post category:Press Release

Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022

Post published:September 30, 2022
Post category:Press Release

Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiatives USA – English USA – English USA – English España – español Latin America – español

Post published:September 23, 2022
Post category:Press Release

Numinus Now Offers Ketamine-Assisted Therapy in Toronto

Post published:September 19, 2022
Post category:Press Release

Weekly Bulletin

Your weekly recap of news and analysis from the psychedelic sector.

Research Review

A monthly review of the most important psychedelics research.

News & Interviews

The latest news from across the psychedelics space.

Psychedelics Patent Trackers

We track the latest patents and filings related to psilocybin, MDMA and DMT.

Psychedelic Legalization & Decriminalization Tracker

Mapping psychedelic drug policy reform across the United States

Psychedelics Drug Development Tracker

From drug discovery to regulatory approval, we map drug development in psychedelics.

Stocks & Companies Directory

A directory of all the major psychedelics stocks, companies and ETFs.

Sector Landscape Map

Explore the Psychedelic Sector Landscape visually using our new tool.

Stock Watchlist

A one-stop overview of psychedelics stocks financial performance.

Numinus Wellness Inc. Reports Q4 2022 and Annual Results

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022

Numinus Re-Launches “Psychedelic Therapy Frontiers” Podcast with additional hosts and topics

Numinus to Participate in Wonderland: Miami on November 3-5, 2022

Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022

Numinus Develops Mushroom Tea for Use in Psychedelic Research

Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022

Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiatives USA – English USA – English USA – English España – español Latin America – español

Numinus Now Offers Ketamine-Assisted Therapy in Toronto

Psychedelic Alpha

Quick Links

Newsletter

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.